SCHEMBL7504292

SCHEMBL7504292

NS(=O)(=O)c1ccc(-c2nc(COc3ccccc3C(=O)O)oc2-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 9/20 0.46
NR4A1 P22736 2/20 0.46
NR4A3 Q92570 2/20 0.46
PPARD Q03181 1/20 0.45
RXRA P19793 8/20 0.45
RXRB P28702 7/20 0.45
RXRG P48443 4/20 0.45
PTGS1 P23219 2/20 0.45
PTGS2 P35354 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ABCC4 O15439 1/20 0.45
C5 P01031 1/20 0.45
LMNA P02545 1/20 0.45
CHRM2 P08172 1/20 0.45
CYP3A4 P08684 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD2 P14416 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
TBXA2R P21731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501583 1.00 NR4A2 (0.46) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7507797 0.90 PTGS2 (0.54) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7504129 0.90 PTGS2 (0.54) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7502967 0.85 PTGS2 (0.51) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7500441 0.85 PTGS2 (0.51) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7498119 0.85 RORC (0.48) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7506180 0.85 RORC (0.48) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL8555570 0.85 POLB (0.43) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL8558894 0.85 RXRA (0.46) NR4A2NR4A1NR4A3PPARDRXRA
SCHEMBL7506158 0.84 CA1 (0.56) NR4A2NR4A1NR4A3PPARDRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO disclosed